4Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
6Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
7Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
8Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
9Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
10Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
6Khwannimit B, Bhurayanontachai R. The performance of customised APACHE Ⅱ and SAPS Ⅱ in predicting mortality of mixed critically ill patients in a Thai medical intensive care unit. [ J 1. Anaesth In- tensive Care ,2009,37:784 - 790.
7Kido H, Okumura Y, Yamada H, et al. Secretory leukoprotease in- hibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up- regulating their levels may have therapeutic potential [ J ]. Biol Chem,2004,385( 11 ) :1029.
8Su LX, Meng K, Zhang X, et al. Diagnosing ventilator-associated pneumonia in critically Ⅲ patients with sepsis [ J ]. Am J Crit Care,2012,21 : e110 - e119.
9Medell M, Hart M, Marrero O, et al. Clinical and microbiological characterization of pneumonia in mechanically ventilated patients [J]. Braz J Infect Dis,2012,16(5) :442 -447.
